Asset Details
Do you wish to reserve the book?
High-Risk Neuroblastoma Tumors with 11q-Deletion Display a Poor Prognostic, Chromosome Instability Phenotype with Later Onset
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
High-Risk Neuroblastoma Tumors with 11q-Deletion Display a Poor Prognostic, Chromosome Instability Phenotype with Later Onset
Do you wish to request the book?
High-Risk Neuroblastoma Tumors with 11q-Deletion Display a Poor Prognostic, Chromosome Instability Phenotype with Later Onset
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
High-Risk Neuroblastoma Tumors with 11q-Deletion Display a Poor Prognostic, Chromosome Instability Phenotype with Later Onset
2010
Overview
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and to aid treatment decisions. MYCN amplification (MNA) alone is an incomplete poor prognostic factor, and chromosome 11q status has recently been included in risk classification. We analyzed 165 NB tumors using high-density SNP microarrays and specifically compared the high-risk groups defined by MNA (n = 37) and 11q-deletion (n = 21). Median patient age at diagnosis was 21 months for MNA tumors and 42 months for 11q-deletion tumors, and median survival time after diagnosis was 16 months for MNA and 40 months for 11q deletion. Overall survival (at 8 years) was ~35% in both groups. MNA and 11q deletion were almost mutually exclusive; only one case harbored both aberrations. The numbers of segmental aberrations differed significantly; the MNA group had a median of four aberrations, whereas the 11q-deletion group had 12. The high frequency of chromosomal breaks in the 11q-deletion group is suggestive of a chromosomal instability phenotype gene located in 11q; one such gene, H2AFX, is located in 11q23.3 (within the 11q-deletion region). Furthermore, in the groups with segmental aberrations without MNA or 11q deletion, the tumors with 17q gain have worse prognosis than those with segmental aberrations without 17q gain, which have a favorable outcome. This study has implications for therapy in different risk groups and stresses that genome-wide microarray analyses should be included in clinical management to fully evaluate risk, aid diagnosis, and guide treatment.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
/ Cancer
/ Comparative genomic hybridization
/ comparative genomic hybridization/SNP array chromosomal aberration
/ Genes
/ Genomics
/ H2AFX
/ Humans
/ Oligonucleotide Array Sequence Analysis
/ patients
/ Polymorphism, Single Nucleotide
/ Reverse Transcriptase Polymerase Chain Reaction
/ risk
/ single nucleotide polymorphism
/ Tumors
